Louvain-la-Neuve, Belgium, March 15, 2022 IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, and Tractebel a global engineering company today announced a new partnership agreement to support IBA’s customers with their proton therapy construction projects.
As part of the agreement, IBA will promote Tractebel’s consulting services to the Group’s prospective customers relating to the design and construction of their proton therapy facilities. Tractebel’s unique experience providing engineering services, consultancy and training in complex healthcare activities will be a valuable extension to IBA’s customer offering, providing customers with support in the construction process. Co-marketing activities and extended services offerings will also be offered to supply IBA’s customers with more detailed information on proton therapy construction projects and Tractebel’s expertise.
The two companies have already collaborated on several projects, such as structural integrity reviews in the event of an earthquake, cost estimation tools for IBA’s Proteus facilities, stability studies related to the installation of a Proteus®ONE[1] system into an existing Proteus®PLUS bunker and engineering support for the design of proton therapy facilities.
Olivier Legrain, Chief Executive Officer at IBA said: “Tractebel has extensive knowledge of the building requirements of our proton therapy systems, making them the perfect design and construction partner. Listening to the market, there is an obvious need for a company that can guide our customers through the building journey and help them to make it as efficient and smooth as possible. We look forward to collaborating with Tractebel to offer an even more complete service to the market.”
Bernard Dereeper, Head of Business Development & Strategy – Business Line Nuclear added: “We are honored to join forces with IBA, a global leader in proton therapy and medical equipment. Combining our expertise in designing medical installations, our nuclear- and radiation-related competences and our multidisciplinary approach with IBA’s world-class radiation therapy technology will enable us to offer high-level and fully integrated services from facilities' design and engineering to the system itself. We are proud that our engineers’ know-how will contribute to improving cancer treatment around the world.”
[1] Proteus®ONE and Proteus®PLUS are brand names of Proteus 235
